welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Long Term Treatment with Sulindac in Familial Adenomatous Polyposis: Is there an Actual Efficiacy in Prevention of Rectal Cancer?
source: Journal of surgical oncology
year: 2000
authors: Tonelli F, Valanzano R, Messerini L, Ficari F
summary/abstract:BACKGROUND AND OBJECTIVES : Ileorectal anastomosis (IRA) is still used in the treatment of familial adenomatous polyposis (FAP). Sulindac appears to induce regression of colorectal adenomas; however, its effects in long-term therapy and in preventing carcinoma remain unclear.
METHODS : Fifteen FAP patients treated by IRA received sulindac (200 mg/day) for a mean period of 48.6 +/- 28.7 (range 12-124) months. Number, size, and type of rectal polyps were assessed by endoscopic and histological evaluation every 6 months.
RESULTS : Significant regression of polyps was observed in all patients after 6 months (P < 0.02). However, after a mean of 48.6 +/- 28.7 months, both number and size of polyps increased again, showing no statistical difference with baseline values. Minute polyps appeared reddish, while the largest lesions were flat or slightly elevated. Endoscopic polypectomy was necessary in 9 patients and transanal surgical excision in 3. Two patients were submitted to restorative proctectomy because of a large polyp with severe dysplasia and a rectal cancer, respectively.
CONCLUSIONS : Sulindac appears to influence the morphological appearance of polyps in FAP patients, inducing apparent regression. However, at a dose of 200 mg, it does not influence the progression of polyps toward a malignant pattern.
organization: University of Florenceread more
expertly curated content related to this topic
-
Clinical Management of Hereditary Colorectal Cancer SyndromesHereditary factors are involved in the d...
-
Macroscopic and Histologic Regression of Duodenal Polyposis with FOLFOX4 Chemotherapy for an Ileal Pouch Adenocarcin...Severe (stage IV) duodenal polyposis is ...
-
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Developm...Sucampo Pharmaceuticals, Inc., a global ...
-
Colon Cancer Combating Recipes (Main Dishes)Are you looking for inspiring recipes fo...
-
Therapeutic Approaches for Patients with Coexisting Familial Adenomatous Polyposis and Colorectal CancerColorectal cancer is a major cause of de...
-
Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC)Hereditary forms of colorectal cancer ac...
-
What is Familial Adenomatous Polyposis or FAP?https://www.youtube.com/watch?v=M7nEbNiE...